Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012:30:357-92.
doi: 10.1146/annurev-immunol-020711-075018. Epub 2012 Jan 3.

Siglecs and immune regulation

Affiliations
Review

Siglecs and immune regulation

Shiv Pillai et al. Annu Rev Immunol. 2012.

Abstract

Sialic acid-binding Ig-like lectins, or Siglecs, vary in their specificity for sialic acid-containing ligands and are mainly expressed by cells of the immune system. Many Siglecs are inhibitory receptors expressed in innate immune cells that regulate inflammation mediated by damage-associated and pathogen-associated molecular patterns (DAMPs and PAMPs). This family also includes molecules involved in adhesion and phagocytosis and receptors that can associate with the ITAM-containing DAP12 adaptor. Siglecs contribute to the inhibition of immune cells both by binding to cis ligands (expressed in the same cells) and by responding to pathogen-derived sialoglycoconjugates. They can help maintain tolerance in B lymphocytes, modulate the activation of conventional and plasmacytoid dendritic cells, and contribute to the regulation of T cell function both directly and indirectly. Siglecs modulate immune responses, influencing almost every cell in the immune system, and are of relevance both in health and disease.

PubMed Disclaimer

Figures

Figure 1
Figure 1
A schematic view of the structure of sialic acid
Figure 2
Figure 2
Glycan binding specificities of selected human and murine Siglecs. *While human CD22 binds to both Neu5Ac and Neu5Gc, murine CD22 is specific for Neu5Gc.
Figure 3
Figure 3
Relative gene expression of (a) conserved and (b) CD33-related (non-conserved) Siglecs across key innate and adaptive immune cells. Values in each panel are normalized to the maximum expression of the respective Siglec across the represented cell types and presented in a linear scale. PMN, Polymorphonuclear leukocyte; RPM, Red pulp macrophage; CD4+ DC, CD4+ dendritic cell; CD8α+ DC, CD8α+ dendritic cell; PDC, Plasmacytoid dendritic cell; LC, Langerhans cell; NK, NK cell; B.Fo, Follicular B cell, B.GC, Germinal center B cell; B.MZ, Marginal Zone B cell; B-1a, B-1a peritoneal B cell; CD4+ T.naive, CD4+ naïve T cell; CD4+ T. memory, CD4+ memory T cell; CD8+ T. naive, CD8+ naive T cell; CD8+ T.memory, CD8+ memory T cell; Treg, Regulatory T cell; γδ T, gamma-delta T cell. This work benefited from data assembled by the ImmGen Consortium Heng, T et al. Immunological Genome Project Consortium. Nat Immunol. 10:1091–1094 (2008).
Figure 3
Figure 3
Relative gene expression of (a) conserved and (b) CD33-related (non-conserved) Siglecs across key innate and adaptive immune cells. Values in each panel are normalized to the maximum expression of the respective Siglec across the represented cell types and presented in a linear scale. PMN, Polymorphonuclear leukocyte; RPM, Red pulp macrophage; CD4+ DC, CD4+ dendritic cell; CD8α+ DC, CD8α+ dendritic cell; PDC, Plasmacytoid dendritic cell; LC, Langerhans cell; NK, NK cell; B.Fo, Follicular B cell, B.GC, Germinal center B cell; B.MZ, Marginal Zone B cell; B-1a, B-1a peritoneal B cell; CD4+ T.naive, CD4+ naïve T cell; CD4+ T. memory, CD4+ memory T cell; CD8+ T. naive, CD8+ naive T cell; CD8+ T.memory, CD8+ memory T cell; Treg, Regulatory T cell; γδ T, gamma-delta T cell. This work benefited from data assembled by the ImmGen Consortium Heng, T et al. Immunological Genome Project Consortium. Nat Immunol. 10:1091–1094 (2008).
Figure 4
Figure 4
Siglecs that lack defined cytoplasmic tail signaling motifs or a charged transmembrane residue. The cytoplasmic tail of Siglec-4 has a tyrosine residue (Y) that does not fit into any known consensus for signaling. It has been referred to in the literature as a Fyn phosphorylation site.
Figure 5
Figure 5
Siglecs that contain ITIM motifs in their cytoplasmic tails A) Human and B) Murine. Siglec 12 is refrred to as Siglec XII in human by convention since the in-frame human form lacks the crucial arginine for sialic acid recognition (but the arginine is present in other primates).
Figure 5
Figure 5
Siglecs that contain ITIM motifs in their cytoplasmic tails A) Human and B) Murine. Siglec 12 is refrred to as Siglec XII in human by convention since the in-frame human form lacks the crucial arginine for sialic acid recognition (but the arginine is present in other primates).
Figure 5
Figure 5
Siglecs that contain ITIM motifs in their cytoplasmic tails A) Human and B) Murine. Siglec 12 is refrred to as Siglec XII in human by convention since the in-frame human form lacks the crucial arginine for sialic acid recognition (but the arginine is present in other primates).
Figure 6
Figure 6
Siglecs that contain a transmembrane lysine (+). A) Human, and B) Murine. Siglec 15 is shown associated with DAP12; it can also associate with DAP10. Murine CD3 has not yet been shown to associate with DAP12 experimentally.
Figure 6
Figure 6
Siglecs that contain a transmembrane lysine (+). A) Human, and B) Murine. Siglec 15 is shown associated with DAP12; it can also associate with DAP10. Murine CD3 has not yet been shown to associate with DAP12 experimentally.
Figure 7
Figure 7
Induction of ligand or Siglec expression by pathogens can regulate inhibitory signaling A. Activation of a TLR by a PAMP results in the generation of a Siglec ligand by regulating an enzyme or enzymes that regulate ligand availability. The generation of a Siglec ligand results in inhibitory signaling being brought into play B. Activation of a TLR by a PAMP results in the induction of Siglec expression. This results in inhibitory signaling being brought into play.
Figure 7
Figure 7
Induction of ligand or Siglec expression by pathogens can regulate inhibitory signaling A. Activation of a TLR by a PAMP results in the generation of a Siglec ligand by regulating an enzyme or enzymes that regulate ligand availability. The generation of a Siglec ligand results in inhibitory signaling being brought into play B. Activation of a TLR by a PAMP results in the induction of Siglec expression. This results in inhibitory signaling being brought into play.
Figure 8
Figure 8
Siglecs may be activated in cis by self-sialoglycoconjugates or in trans by sialylated pathogens A. Tonic inhibition refers to inhibitory signaling based on ongoing ligation in cis of a Siglec by its ligand B. A sialylated pathogen may displace a cis-ligand and more potently engage an inhibitory Siglec.
Figure 9
Figure 9
Engagement of a DAP12 associated Siglec may result in the induction and/or activation of proteins that can compromise TLR signaling and reduce the secretion of type I interferons in plasmacytoid dendritic cells.
Figure 10
Figure 10
A 9-O acetyl sialic acid acetyltransferase and a 9-O acetyl sialic acid acetylesterase (SIAE) regulate the availability of siglec ligands in B cells.
Figure 11
Figure 11
SIAE may maintain clonal ignorance in B cells preventing the activation of weakly self-reactive B cells. Activation of weakly self-reactive B cells would permit T-B collaboration and consequent somatic mutation of the B cell, potentially making it strongly self-reactive.
Figure 12
Figure 12
SIAE may permit promiscuous activation of B cells that might in turn facilitate the induction of CD4+ memory T cells that might be linked to disease.

References

    1. Sharon N. Advanced Book Program. Reading, Mass: Addison-Wesley Pub. Co; 1975. Complex carbohydrates, their chemistry, biosynthesis, and functions: a set of lecture notes; p. xix.p. 466.p. 7.
    1. Laine RA. A calculation of all possible oligosaccharide isomers both branched and linear yields 1.05 × 10(12) structures for a reducing hexasaccharide: the Isomer Barrier to development of single-method saccharide sequencing or synthesis systems. Glycobiology. 1994;4:759–67. The calculations made here emphasize the structural diversity that carbohydrates can generate. - PubMed
    1. Varki A. Sialic acids. In: Varki A, Cummings RD, Esko JD, Freeze HH, Stanley P, Bertozzi CR, Hart GW, Etzler ME, editors. Essentials of Glycobiology. Chapter 15. Cold Spring Harbor (NY): 2009. - PubMed
    1. Stamenkovic I, Seed B. The B-cell antigen CD22 mediates monocyte and erythrocyte adhesion. Nature. 1990;345:74–7. - PubMed
    1. Stamenkovic I, Sgroi D, Aruffo A, Sy MS, Anderson T. The B lymphocyte adhesion molecule CD22 interacts with leukocyte common antigen CD45RO on T cells and alpha 2-6 sialyltransferase, CD75, on B cells. Cell. 1991;66:1133–44. - PubMed

Publication types

Substances